Table 2.
In‐hospital treatment and outcomes
| Patients who was discharged before February 17th, 2021, N = 769 | Patients who was discharged between February 18th, 2021 and March 30th, 2021, N = 802 | p value | |
|---|---|---|---|
| Therapeutic anticoagulation, n (%) | 329 (42.8) | 177 (22.1) | <0.001 |
| Prophylactic anticoagulation, n (%) | 436 (56.7) | 616 (76.8) | <0.001 |
| Use of Tocilizumab, n (%) | 22 (2.9) | 51 (6.4) | 0.002 |
| Convalescent plasma, n (%) | 407 (52.9) | 116 (14.5) | <0.001 |
| ICU admission, n (%) | 229 (29.8) | 211 (26.3) | 0.14 |
| Endotracheal intubation, n (%) | 126 (16.4) | 119 (14.8) | 0.44 |
| Acute kidney injury, n (%) | 152 (19.8) | 140 (17.5) | 0.27 |
| In‐hospital mortality, n (%) | 156 (20.3) | 175 (21.8) | 0.49 |
Abbreviation: ICU, intensive care unit.